Document is current
Any future updates will be listed below
-
Authors
Li, Xiumin
Wang, Xudong
Wang, Hao
Zuo, Donghua
Xu, Jianpo
Feng, Yixuan
Xue, Dixuan
Zhang, Li
Lin, Lin
Zhang, Jin
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 12 November 2024
First Online: 28 November 2024
Declarations
:
: The clinical protocol was reviewed and approved by the Clinical Research Ethics Committee of Linyi Cancer Hospital (2023IIT). The animal study was performed in compliance with relevant regulatory standards.
: Jin Zhang is a scientific co-founder of CellOrigin. Hao Wang, Jianpo Xu, Yixuan Feng, Li Zhang, and Lin Lin are employees of CellOrigin. The remaining authors declare no competing interests.
